B·R·A·H·M·S KRYPTOR biomarkers for oncology labs
When used in conjunction with other clinical findings to assess cancer, tumor marker testing can improve clinical decision making, helping you to manage your patients more effectively.
A diverse selection of Thermo Scientific B·R·A·H·M·S tumor markers are available for assessment and monitoring of cancer.
Biomarkers in oncology: providing gold standard patient management
Tumor markers are a powerful tool in therapy control and follow-up of cancer patients, and precision is a critical parameter when choosing an assay method.
The course of a cancer disease is usually reflected by the individual course of tumor markers, and the individual course is derived from serial determinations of the leading tumor marker. The dynamics of these serial measurements are more important than the concentration of a single determination, therefore it is important to have reliable and precise measurement of the analyte.1
High-quality B·R·A·H·M·S KRYPTOR immunoassays provide exceptional intra-and interassay precision due to homogenous assay design without any washing or separation step. This extraordinary precision supports confident decision making on clinical status and further diagnostic measures for optimal patient management.
Example of an individual course of CA 15-3 in breast cancer by courtesy of Dr. P. Stieber
Discover the clinical evidence behind our B·R·A·H·M·S CgA II KRYPTOR assay: CASPAR study (Chromogranin A Surveillance biomarker in Patients with Carcinoids)
A prospective, multi-center, observational study with 153 evaluable neuroendocrine tumor patients was performed to validate the performance of Thermo Scientific B·R·A·H·M·S CgA II KRYPTOR Assay in monitoring grade 1 and grade 2 GEP-NET progressive or non-progressive disease within 32 months.
Discover the KRYPTOR Analyzer for your oncology lab
Thermo Scientific B·R·A·H·M·S KRYPTOR Analyzers are fully automated random-access benchtop immunoanalyzers that use Nobel prize winning TRACE technology to ensure fast and reliable test results for essential indications.
Drive uncompromised quality to support safe patient management.
- Easy and straightforward laboratory routine with less operator intervention
- Self-determining dilution factor (SDDF) & auto dilutions greatly reduce sample re-runs & eliminate hands-on time
- Environmentally friendly design that produces less material waste
Explore our complete portfolio for cancer biomarker testing
Discover our collection of tumor markers, including B·R·A·H·M·S CgA II KRYPTOR, our fully automated assay for fast, precise, and efficient monitoring of neuroendocrine tumors.
References:
- Thomas L. Clinical Laboratory Diagnostics. TM-Books. Verlagsgesellschaft Frankfurt/Main, 938
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S is a registered trademark of B·R·A·H·M·S GmbH.
KRYPTOR and TRACE are trademarks of Cisbio Bioassays, licensed for use by B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific. Nobel Prize is a registered trademark of the Nobel Foundation.